Profile data is unavailable for this security.
About the company
Impact Healthcare REIT PLC is a real estate investment trust. The Company provides shareholders with an attractive return, by investing in a diversified portfolio of United Kingdom healthcare real estate assets, in particular residential and nursing care homes. Its strategy is to identify new healthcare properties and tenants who diversify its portfolio and deliver economies of scale. It works with its tenants to implement asset management opportunities that benefit the tenant, residents, and shareholders. Its objective is to provide shareholders with attractive and sustainable returns, in the form of quarterly dividends, while also generating growth in net asset values over the medium term. It acquires, owns, leases, renovates, extends, redevelops healthcare real estate assets in the United Kingdom, in particular elderly care homes, and to lease those assets to care home operators and other healthcare service providers. The Company's investment manager is Impact Health Partners LLP.
- Revenue in GBP (TTM)50.53m
- Net income in GBP48.83m
- Incorporated2016
- Employees0.00
- LocationImpact Healthcare REIT plcThe Scalpel, 18Th Floor, 52 Lime StreetLONDON EC3M 7AFUnited KingdomGBR
- Phone+44 20 7409 0181
- Websitehttps://www.impactreit.uk/
Profile
| Management group(s) | Impact health Partners LLP |
|---|---|
| AIC sector | Property - UK Healthcare |
| ISIN | GB00BYXVMJ03 |
| Launch date | 07 Mar 2017 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | GBP |
Objective
To seek to provide Shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth through exposure to a diversified portfolio of Healthcare Real Estate Assets. The investment policy is to acquire, own, lease, renovate, extend and redevelop high quality, Healthcare Real Estate Assets in the UK, in particular residential care homes and to lease those assets to care home operators and other healthcare service providers under full repairing and insuring leases.
Managed by
| Andrew Cowley, Mahesh Patel |
|---|
Management & contract fees
The advisory fee is 1% p.a. of the Company's NAV up to GBP 500m and 0.70% thereafter, payable quarterly. The Investment Management Agreement may be terminated by either party on six months notice,
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Nippon Active Value Fund PLC | 53.13m | 47.56m |
| CT Private Equity Trust PLC | 29.48m | 13.78m |
| Henderson Eurotrust PLC | 31.38m | 27.02m |
| Henderson International Income Trust PLC | 18.14m | 12.76m |
| Invesco Bond Income Plus Ltd | 36.48m | 31.82m |
| CT UK Capital and Income Invst Trust PLC | 41.80m | 38.32m |
| Lowland Investment Company P L C | 57.32m | 52.79m |
| Baillie Gifford Shin Nippon PLC | -75.99m | -81.91m |
| Baillie Gifford European Growth Trst PLC | 24.20m | 27.88m |
| abrdn Asian Income Fund Limited | 16.30m | 8.74m |
| Impact Healthcare REIT PLC | 50.53m | 48.83m |
| Abrdn UK Smlr Cmpn Grth Trst PLC | 2.30m | -3.53m |
| Henderson Far East Income Limited | -46.86m | -56.24m |
| Fidelity Asian Values PLC | 6.02m | -5.81m |
| Ashoka India Equity Investment Trust PLC | 69.74m | 54.52m |
| abrdn New India Investment Trust PLC | -3.38m | -13.30m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Quilter Investors Ltd.as of 15 Apr 2024 | 52.46m | 12.66% |
| Valu-Trac Investment Management Ltd.as of 28 Mar 2024 | 23.35m | 5.64% |
| Brooks Macdonald Asset Management Ltd.as of 21 Mar 2024 | 21.32m | 5.15% |
| Schroder & Co. Ltd.as of 21 Mar 2024 | 19.62m | 4.73% |
| Royal London Asset Management Ltd.as of 21 Mar 2024 | 18.82m | 4.54% |
| Premier Fund Managers Ltd.as of 21 Mar 2024 | 18.33m | 4.42% |
| Newton Investment Management Ltd.as of 27 Mar 2023 | 14.36m | 3.47% |
| Hargreaves Lansdown Asset Management Ltd.as of 21 Mar 2024 | 13.17m | 3.18% |
| Baillie Gifford & Co.as of 26 Mar 2021 | 11.76m | 2.84% |
| Evelyn Partners Investment Management LLPas of 02 Apr 2024 | 10.07m | 2.43% |
